COVID-19 and Cancer: Screenings Rebound but Study Finds Disparities

Cancer screenings rebounded after a dramatic decline in the first months of the COVID-19 pandemic, but a new study found an increase in disparities among some screening tests during the pandemic. Dana-Farber Cancer Institute's Toni Choueiri, MD, and Chris Labaki, MD, detail the findings. Press Release:


August 19, 2021

Created by


Related Presenters

Toni Choueiri, MD

Toni Choueiri, MD

Medical Oncology

Dr. Toni K. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI)/Brigham and Women’s Hospital and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School.

View Profile